Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Rhone-Poulenc Rorer

This article was originally published in The Tan Sheet

Executive Summary

Rhone-Poulenc Rorer: Acquires from Rhone-Poulenc two overseas drug businesses -- Cooperation Pharmaceutique Francaise (Cooper) and Brazil-based Rhodia -- for $260 mil. in cash and preferred shares issued by RPR's French subsidiary RPR SA, the firm reported May 22. RPR is characterizing the deal as further consolidation of the Rhone-Poulenc pharmaceutical businesses under RPR, which is 68% owned by Rhone-Poulenc. Rhone-Poulenc SA acquired Cooper in April 1994 ("The Tan Sheet" Feb. 28, 1994, p. 1)). The French firm had $450 mil. in drug and surgical supply sales in 1994. Rhone-Poulenc Labo Managing Director Yves Baja will have responsibility for Cooper..
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083873

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel